Truist analyst Michael Lewis raised the firm’s price target on Omega Healthcare (OHI) to $46 from $44 and keeps a Hold rating on the shares. The stock has surged 16% in the past month versus 3% for the VNQ ETF, and is trading near its highest price to FFO multiple in more than a decade, which appears roughly fair given the favorable fundamentals and healthy forecasted earnings growth, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $48 from $45 at Wells Fargo
- Omega, Alphabet, Honeywell, Freeport, DoorDash: Trending by Analysts
- Omega Healthcare initiated with a Buy at UBS
- Omega Healthcare: Strong Buy Rating Driven by Strategic Investments and Positive Market Trends
- Omega Healthcare price target raised to $48 from $46 at BofA